BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has announced that it will report its fiscal 2024 fourth quarter and full year financial results on Thursday, Nov. 7, 2024. A news release will be issued at approximately 6:30 a.m. ET, with related presentation materials available on the company's investor relations website.
BD management will host an audio webcast at 8 a.m. ET on the same day to discuss the financial results and provide updates on operations and strategy. The company has also announced dates for its fiscal 2025 quarterly earnings webcasts, which are scheduled for February 6, May 1, July 31, and November 6, 2025.
BD (Becton, Dickinson and Company) (NYSE: BDX), una delle principali aziende globali nel settore della tecnologia medica, ha annunciato che presenterà i suoi risultati finanziari per il quarto trimestre e l'intero anno fiscale 2024 il giovedì 7 novembre 2024. Un comunicato stampa sarà pubblicato intorno alle 6:30 a.m. ET, con materiali di presentazione correlati disponibili sul sito web per le relazioni con gli investitori dell'azienda.
La direzione di BD ospiterà un audiowebcast alle 8 a.m. ET lo stesso giorno per discutere i risultati finanziari e fornire aggiornamenti sulle operazioni e sulla strategia. L'azienda ha inoltre annunciato le date per i suoi webcast trimestrali sui risultati fiscali 2025, che sono programmati per il 6 febbraio, il 1° maggio, il 31 luglio e il 6 novembre 2025.
BD (Becton, Dickinson and Company) (NYSE: BDX), una empresa líder en tecnología médica a nivel global, ha anunciado que reportará sus resultados financieros del cuarto trimestre y del año fiscal 2024 el jueves 7 de noviembre de 2024. Se emitirá un comunicado de prensa aproximadamente a las 6:30 a.m. ET, y se podrán encontrar materiales de presentación relacionados en el sitio web de relaciones con inversores de la empresa.
La dirección de BD llevará a cabo un audiowebcast a las 8 a.m. ET el mismo día para discutir los resultados financieros y proporcionar actualizaciones sobre operaciones y estrategia. La empresa también ha anunciado las fechas de sus webcasts trimestrales de ganancias fiscales 2025, que están programados para el 6 de febrero, el 1 de mayo, el 31 de julio y el 6 de noviembre de 2025.
BD (Becton, Dickinson and Company) (NYSE: BDX)는 세계적인 의료 기술 회사로, 2024 회계연도 4분기 및 연간 재무 결과를 2024년 11월 7일 목요일에 보고할 것이라고 발표했습니다. 관련 발표 자료는 오전 6시 30분 ET에 보도자료가 발행될 때 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다.
BD 경영진은 같은 날 오전 8시 ET에 오디오 웹캐스트를 주최하여 재무 결과를 논의하고 운영 및 전략에 대한 업데이트를 제공할 예정입니다. 회사는 또한 2025 회계연도 분기 실적 웹캐스트 날짜를 발표했으며, 이는 2025년 2월 6일, 5월 1일, 7월 31일, 11월 6일로 예정되어 있습니다.
BD (Becton, Dickinson and Company) (NYSE: BDX), une entreprise leader dans le domaine de la technologie médicale à l'échelle mondiale, a annoncé qu'elle publiera ses résultats financiers pour le quatrième trimestre et l'année fiscale 2024 le jeudi 7 novembre 2024. Un communiqué de presse sera diffusé aux alentours de 6h30 ET, avec les documents de présentation disponibles sur le site des relations investisseurs de l'entreprise.
La direction de BD animera un webinaire audio à 8h ET le même jour pour discuter des résultats financiers et fournir des mises à jour sur les opérations et la stratégie. L'entreprise a également annoncé les dates de ses webinaires trimestriels sur les résultats financiers de l'exercice 2025, qui sont programmés pour le 6 février, le 1er mai, le 31 juillet et le 6 novembre 2025.
BD (Becton, Dickinson and Company) (NYSE: BDX), ein führendes globales Unternehmen der Medizintechnologie, hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das gesamte Geschäftsjahr 2024 am Donnerstag, den 7. November 2024 bekannt geben wird. Eine Pressemitteilung wird etwa um 6:30 Uhr ET veröffentlicht, und die dazugehörigen Präsentationsmaterialien werden auf der Investor-Relations-Website des Unternehmens zur Verfügung stehen.
Das Management von BD wird am selben Tag um 8 Uhr ET ein Audio-Webcast veranstalten, um die Finanzergebnisse zu besprechen und Updates zu den Operationen und der Strategie zu geben. Das Unternehmen hat zudem die Termine für seine quartalsweisen Webcasts zu den Finanzergebnissen 2025 bekannt gegeben, die für den 6. Februar, den 1. Mai, den 31. Juli und den 6. November 2025 geplant sind.
- None.
- None.
Announces Dates for Fiscal 2025 Quarterly Earnings Webcasts
A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's fiscal 2024 fourth quarter and full year, which ended on Sept. 30, 2024.
BD management will host an audio webcast at 8 a.m. ET on Nov. 7, 2024 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
In addition, the company announced that it plans to host webcasts to discuss its fiscal year 2025 quarterly financial results on the following dates:
- First Quarter Fiscal 2025 – February 6, 2025
- Second Quarter Fiscal 2025 – May 1, 2025
- Third Quarter Fiscal 2025 – July 31, 2025
- Fourth Quarter Fiscal 2025 – November 6, 2025
BD will issue a detailed announcement prior to each quarter's webcast confirming the date and time of the earnings news release and webcast for that quarter.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-announce-its-fiscal-2024-fourth-quarter-and-full-year-financial-results-302273299.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
When will BD (BDX) report its fiscal 2024 fourth quarter and full year financial results?
What time is BD's (BDX) audio webcast scheduled for discussing the fiscal 2024 Q4 results?
Where can investors access BD's (BDX) fiscal 2024 Q4 financial results and presentation materials?
What are the dates for BD's (BDX) fiscal 2025 quarterly earnings webcasts?
